Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
On Wednesday, Aileron Therapeutics Inc (NASDAQ; ALRN) revealed topline data from Cohort 2 of its Phase 1b trial of safety and ...
Big News Network.com1 小时
ANGLE presents two posters at EACR
This workflow provides an efficient, standardised solution for the characterisation of multiple CTC phenotypes (epithelial, mesenchymal and those transitioning ... This method of molecular ...